301 related articles for article (PubMed ID: 38818292)
1. Genetic screening of liver cancer: State of the art.
Peruhova M; Banova-Chakarova S; Miteva DG; Velikova T
World J Hepatol; 2024 May; 16(5):716-730. PubMed ID: 38818292
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy for early detection of hepatocellular carcinoma.
Manea I; Iacob R; Iacob S; Cerban R; Dima S; Oniscu G; Popescu I; Gheorghe L
Front Med (Lausanne); 2023; 10():1218705. PubMed ID: 37809326
[TBL] [Abstract][Full Text] [Related]
3. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook.
Ng CKY; Di Costanzo GG; Terracciano LM; Piscuoglio S
Front Med (Lausanne); 2018; 5():78. PubMed ID: 29632864
[TBL] [Abstract][Full Text] [Related]
4. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
6. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma.
Liu M; Zhang Z; Zhang W; Liu SM
WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374
[TBL] [Abstract][Full Text] [Related]
7. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Review of Screening Methods for Ovarian Masses: Towards Earlier Detection.
Sahu SA; Shrivastava D
Cureus; 2023 Nov; 15(11):e48534. PubMed ID: 38084173
[TBL] [Abstract][Full Text] [Related]
9. The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma.
Ding Y; Yao J; Wen M; Liu X; Huang J; Zhang M; Zhang Y; Lv Y; Xie Z; Zuo J
PeerJ; 2022; 10():e13473. PubMed ID: 35602894
[TBL] [Abstract][Full Text] [Related]
10. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments.
Di Capua D; Bracken-Clarke D; Ronan K; Baird AM; Finn S
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439082
[TBL] [Abstract][Full Text] [Related]
11. Beyond genetics: Exploring the role of epigenetic alterations in breast cancer.
Prabhu KS; Sadida HQ; Kuttikrishnan S; Junejo K; Bhat AA; Uddin S
Pathol Res Pract; 2024 Feb; 254():155174. PubMed ID: 38306863
[TBL] [Abstract][Full Text] [Related]
12. Using cell-free DNA for HCC surveillance and prognosis.
Tran NH; Kisiel J; Roberts LR
JHEP Rep; 2021 Aug; 3(4):100304. PubMed ID: 34136776
[TBL] [Abstract][Full Text] [Related]
13. Bibliometric study of immunotherapy for hepatocellular carcinoma.
Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
[TBL] [Abstract][Full Text] [Related]
14. DNA markers in molecular diagnostics for hepatocellular carcinoma.
Su YH; Lin SY; Song W; Jain S
Expert Rev Mol Diagn; 2014 Sep; 14(7):803-17. PubMed ID: 25098554
[TBL] [Abstract][Full Text] [Related]
15. Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas.
Dhayat SA; Yang Z
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1625-1645. PubMed ID: 32338295
[TBL] [Abstract][Full Text] [Related]
16. Detection of MET gene somatic mutations in hepatocellular carcinoma of Egyptian patients using next-generation sequencing.
Ahmed E; El-Dien A N; Sabet S; Khalifa M; El Hamshary M
Biomarkers; 2023 Jun; 28(4):379-386. PubMed ID: 36825430
[TBL] [Abstract][Full Text] [Related]
17. The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance.
Allen TA
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611055
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for hepatocellular carcinoma: What's new on the horizon?
Ocker M
World J Gastroenterol; 2018 Sep; 24(35):3974-3979. PubMed ID: 30254402
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing in liquid biopsy: cancer screening and early detection.
Chen M; Zhao H
Hum Genomics; 2019 Aug; 13(1):34. PubMed ID: 31370908
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
